EssilorLuxottica (OTCMKTS:ESLOY) Shares Gap Down – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) shares gapped down before the market opened on Thursday . The stock had previously closed at $167.00, but opened at $157.89. EssilorLuxottica shares last traded at $157.6505, with a volume of 155,162 shares changing hands.

Wall Street Analyst Weigh In

ESLOY has been the subject of a number of research reports. The Goldman Sachs Group restated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Kepler Capital Markets raised shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Citigroup reaffirmed a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. HSBC raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Wednesday, January 14th. Finally, Zacks Research downgraded EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, EssilorLuxottica presently has an average rating of “Buy”.

EssilorLuxottica Stock Down 7.2%

The company has a 50-day moving average of $159.70 and a 200 day moving average of $163.41. The company has a debt-to-equity ratio of 0.18, a current ratio of 0.97 and a quick ratio of 0.67.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.